// November 11, 2022
Latest nitrosamines recall spotlighting need to control pharmaceutical impurities
Revised on: January 17, 2023
Revised on: January 17, 2023
Another public health crisis looms in the wake of the COVID-19 pandemic.
To those in the pharmaceutical industry, USP may be both familiar and a little myster
Innovations in biotherapeutic medicines are advancing at an unprecedented pace and offer great pr